- Investing Ideas
- /
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
5
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
5 companies
SanBio
Market Cap: JP¥152.1b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.
4592
JP¥1,949.00
7D
14.8%
1Y
188.7%
GNI Group
Market Cap: JP¥142.7b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,563.00
7D
3.9%
1Y
-17.7%
Noile-Immune Biotech
Market Cap: JP¥6.7b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥155.00
7D
6.2%
1Y
-12.9%
Japan Tissue Engineering
Market Cap: JP¥21.7b
Engages in the regenerative medicine business in Japan.
7774
JP¥535.00
7D
-1.3%
1Y
12.6%
Takara Bio
Market Cap: JP¥100.4b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥834.00
7D
1.7%
1Y
-17.3%